Should I Get The Rsv Vaccine Pregnant?

When It Makes Sense

• Good fit: You have been identified by your obstetrician as high risk for severe RSV infection (e.g., chronic lung disease, immunocompromise) and the provider recommends vaccination during the second or third trimester.
• Good fit: You are in a region experiencing a significant RSV outbreak and receiving the vaccine could provide maternal antibodies that cross the placenta, offering early protection to your newborn.

When You Should Avoid It

• Warning sign: You have a known severe allergy to any ingredient of the RSV vaccine; vaccination could trigger a serious allergic reaction.
• Warning sign: You are in the first trimester and there is insufficient safety data for early‑pregnancy exposure, making postponement or an alternative approach advisable.

Pros and Cons

Pros

• Maternal vaccination can generate antibodies that cross the placenta, potentially reducing the infant’s risk of severe RSV disease after birth.
• Protecting the mother from RSV may decrease illness‑related complications during pregnancy, such as fever or respiratory distress.

Cons

• Long‑term safety data specifically for pregnant populations are still limited, so unknown risks cannot be fully ruled out.
• Side effects are generally mild (injection‑site soreness, low‑grade fever) but may be uncomfortable during pregnancy, and not all healthcare systems have the vaccine readily available for pregnant people.

Decision Checklist

• Have you discussed the RSV vaccine with your obstetrician or a maternal‑fetal medicine specialist?
• Do you have any contraindications, such as a severe allergy to vaccine components?
• Is the timing of the vaccine within the gestational window recommended by current guidelines (typically second or early third trimester)?

Alternatives to Consider

If vaccination feels uncertain, you can focus on non‑vaccine strategies: practice rigorous hand hygiene, avoid close contact with individuals who have respiratory infections, and limit exposure to crowded indoor settings during RSV season. For newborns at very high risk, pediatricians may consider monoclonal antibody prophylaxis (e.g., palivizumab) after birth. Consulting your provider about the timing of your pregnancy relative to RSV season can also help you plan safer exposure windows.

Final Recommendation

For pregnant individuals who are medically high‑risk or living in an area with active RSV transmission, and who receive a clear recommendation from their healthcare provider, receiving the RSV vaccine during the appropriate gestational window is a reasonable choice. In most other cases, especially early in pregnancy or when contraindications exist, it is prudent to discuss alternatives and follow infection‑prevention measures while awaiting more extensive safety data. Always make the final decision in partnership with a qualified medical professional.